Latest Headlines
Sep 14
2020
In a new study, a team of Packard scientists identified a key intersection between two major pathways of pathology in ALS and frontotemporal dementia (FTD)
Read the full article in Science Translational Medicine
Sep 3
2020
Results of a new Phase 2 randomized clinical trial in 137 patients with ALS showed that treatment with the drugs sodium phenylbutyrate and taurursodiol, combined together, could significantly slow functional decline over 24 weeks compared to placebo.
Read more about the trial in a recent article on www.nytimes.com
Aug 14
2020
The Packard Center welcomed Alyssa Coyne, PHD from Johns Hopkins University to a recent Investigator's meeting.
Aug 14
2020
The Packard Center welcomed Adrian Isaacs, PHD from University College London to a recent Investigator's meeting.
Jul 23
2020
Packard scientist Mervyn Monteiro showed that ALS-linked mutations in UBQLN2 interferes with autophagy by blocking an acidification step critical for the process.
Jul 10
2020
The Packard Center welcomed Edward Lee, PHD from the University of Pennsylvania to a recent Investigator's meeting
Jul 10
2020
The Packard Center welcomed Magda Polymenidou, PHD from the University of Zurich to a recent Investigator's meeting
Jul 9
2020
In a new study, Packard scientist Jiou Wang and colleagues showed that RNA structures called G-quadruplexes play a role in the formation and function of a type of granule called a paraspeckle.
Click here to read the full study:
Jun 15
2020
The Packard Center welcomed Fen-Biao Gao from the University of Massachucetts Medical School to a recent Investigator's meeting
Jun 15
2020
The Packard Center welcomed Paschalis Kratsios from the University of Chicago to a recent Investigator's meeting.
